Article No
MON3347
Additional Information | Smooth Muscle Myosin, heavy chain (SMMS-1) is a cytoplasmic structural protein that is a major component of the contractile apparatus of the smooth muscle cells. SMMS-1 is also a myoepitheliumassociated protein. Anti-SMMS-1 is a mouse monoclonal antibody to smooth muscle myosin, heavy chain that reacts with human visceral and vascular smooth muscle cells. The antibody also reacts with human myoepithelial cells. It is very helpful in distinguishing between benign sclerosing breast lesions and infiltrating carcinomas in difficult cases since it strongly stains the myoepithelial layer in the benign lesions while it is negative in the infiltrating carcinomas. |
Application | IHC |
Article No | MON3347 |
Country Availability | SE, FI, DK, NO, IS, EE, LV, LT |
Clone | SMMS-1 |
Clone Type | monoclonal |
Conjugation | Unconjugated |
Description | Mouse anti-Smooth Muscle Myosin, clone SMMS-1 |
Supplier | SANBIO bv/Monosan |
Format | - |
Immunogen | Unknown or proprietery to MONOSAN and/or its suppliers |
Isotype | IgG1 k |
Notes | Smooth Muscle Myosin, heavy chain (SMMS-1) is a cytoplasmic structural protein that is a major component of the contractile apparatus of the smooth muscle cells. SMMS-1 is also a myoepitheliumassociated protein. Anti-SMMS-1 is a mouse monoclonal antibody to smooth muscle myosin, heavy chain that reacts with human visceral and vascular smooth muscle cells. The antibody also reacts with human myoepithelial cells. It is very helpful in distinguishing between benign sclerosing breast lesions and infiltrating carcinomas in difficult cases since it strongly stains the myoepithelial layer in the benign lesions while it is negative in the infiltrating carcinomas. |
Product Type | Antibodies Primary |
Protocol | IHC-P (1:100-1:500) |
Shipping Information | blue ice |
Size | 1 ml |
Source / Host | mouse |
Species Reactivity | human |
Storage | 2-8°C |
Substrate / Buffer | Tris Buffer, pH 7.3-7.7, containing 1% BSA and <0.1% Sodium Azide |
Product Page Updated | 2024-01-12T18:37:31.725Z |